HighVista Strategies’s Immunogen Inc IMGN Stock Holding History

HighVista Strategies’s Portfolio IMGN Stock Details IMGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-144,772	Closed	-$4.29M	–	166
2023 Q4	$4.29M	Hold	144,772	–	–	1.56%	9
2023 Q3	$2.3M	Buy	+144,772	New	+$2.41M	1.06%	24
2022 Q4	–	Sell	-65,151	Closed	-$311K	–	131
2022 Q3	$311K	Sell	65,151 -126,575	-66%	-$667K	0.18%	93
2022 Q2	$863K	Buy	191,726 +114,032	+147%	+$495K	0.52%	42
2022 Q1	$370K	Buy	+77,694	New	+$430K	0.24%	83
2021 Q4	–	Sell	-24,088	Closed	-$137K	–	131
2021 Q3	$137K	Buy	24,088 +9,159	+61%	+$52.9K	0.09%	79
2021 Q2	$99K	Hold	14,929	–	–	0.07%	88
2021 Q1	$121K	Sell	14,929 -7,171	-32%	-$58.6K	0.09%	89
2020 Q4	$143K	Sell	22,100 -4,700	-18%	-$27.4K	0.09%	76
2020 Q3	$96K	Buy	+26,800	New	+$108K	0.07%	81

Other funds holding IMGN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

HighVista Strategies's IMGN Position: Q1 2024 in Review

HighVista Strategies sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 144,772 shares — an estimated $4.29M sold.

HighVista Strategies first reported a position in IMGN in Q3 2020 and held it in 10 quarters. The position peaked at $4.29M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

HighVista Strategies reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
HighVista Strategies sold 144,772 Immunogen Inc shares in Q1 2024, an estimated $4.29M.
HighVista Strategies first reported a position in Immunogen Inc in Q3 2020 and held it in 10 quarters.
HighVista Strategies's Immunogen Inc position peaked at $4.29M in Q4 2023.
3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on HighVista Strategies's 13F filing for Q1 2024, filed 15 May 2024.